Literature DB >> 9791386

Guidelines for hypertension treatment: applications for primary care practice--a review of the JNC VI report.

L M Alexander1.   

Abstract

The Joint National Committee's report on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure was released in November 1997. With its release, an increased emphasis on "treating the patient, not just the number" has taken place. The report provides a comprehensive review of recent clinical evidence that helps guide clinical decision making in the care of the hypertensive patient. A new disease classification system entitled "risk stratification" is introduced and takes into account comorbid conditions that are present for many hypertensive individuals. This risk stratification is then linked to treatment strategies and provides a concise decision analysis framework to aid in clinical decision making. Community-based prevention strategies are also highlighted and should raise the awareness of clinicians to adopt these recommendations and integrate them more aggressively into daily practice. Increased emphasis on patient compliance to improve overall hypertension control rates is also presented. Maximum efficacy through once-daily dosing and fixed-dose combinations are reviewed in the report. The JNC report is a comprehensive resource for clinicians in primary care practice. Its evidenced-based approach is a wonderful teaching tool for those clinicians who also serve as clinical educators in primary care.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9791386

Source DB:  PubMed          Journal:  Lippincotts Prim Care Pract        ISSN: 1088-5471


  2 in total

1.  Patient registries for substance use disorders.

Authors:  Betty Tai; Lian Hu; Udi E Ghitza; Steven Sparenborg; Paul VanVeldhuisen; Robert Lindblad
Journal:  Subst Abuse Rehabil       Date:  2014-07-24

Review 2.  The hypertension management program: identifying opportunities for improvement.

Authors:  Susan K Maue; James H Jackson; Bruce A Weiss; Marc L Rivo; Vishu Jhaveri; Barbara Lennert
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.